Back
Renalytix PLC Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Sell
1
RNLX
Renalytix PLC
Last Price:
0.39
Seasonality Move:
-10.17%
Sell
42
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
1.11
Seasonality Move:
-6.45%
Sell
1
Renalytix PLC (RNLX)
is a Sell
Is Renalytix PLC a Buy, Sell or Hold?
- The current Renalytix PLC [RNLX] share price is $0.44. The Score for RNLX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- RNLX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $1.28. The Score for BDRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNLX Stock Price Chart
What is Renalytix PLC's stock price today?
-
The Renalytix PLC share price today is $0.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNLX is experiencing slight buying pressure.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $1.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
RNLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 29.6 | Sell |
| Chaikin Money Flow: | 5415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.75) | Sell |
| Bollinger Bands (100): | (0.4 - 0.98) | Sell |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 51.52 | Buy |
| Chaikin Money Flow: | -8860010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 1.44) | Buy |
| Bollinger Bands (100): | (0.94 - 1.88) | Sell |
RNLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.54 | Sell |
| 20-day SMA: | 0.62 | Sell |
| 50-day SMA: | 0.76 | Sell |
| 200-day SMA: | 1.06 | Sell |
| 8-day EMA: | 0.53 | Sell |
| 20-day EMA: | 0.61 | Sell |
| 50-day EMA: | 0.7 | Sell |
| 200-day EMA: | 1.14 | Sell |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.31 | Sell |
| 20-day SMA: | 1.2 | Buy |
| 50-day SMA: | 1.09 | Buy |
| 200-day SMA: | 2.83 | Sell |
| 8-day EMA: | 1.39 | Sell |
| 20-day EMA: | 1.23 | Buy |
| 50-day EMA: | 1.23 | Buy |
| 200-day EMA: | 36.42 | Sell |
Renalytix PLC Earnings Growth & RNLX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.05 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.03 per share.
Renalytix PLC Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals Plc Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||